The NextGen Clinical Trial Investigator Training is a virtual five-session educational program designed for investigators who currently lead or would like to lead clinical trials. The series includes lectures and panel discussions from leaders across the University of Missouri System, as well as Washington University, to define the regulatory, operational and ethical components of clinical trials, with the goal of developing a skilled workforce that provides the highest level of patient safety, teamwork and data quality. The program also covers institution-specific resources for investigators.

Timeframe: Five weeks, starting April 5 through May 3

• 5-6:30 p.m. - session program
• Additional videos to view to complete coursework

Follow the links below for speaker information at each session.

April 5 - Session 1: What is a Clinical Trial & Patient Perspective
April 12 - Session 2: Audit Ready Trials & Lessons Learned
April 19 - Session 3: Patient Recruitment & Informed Consent
April 26 - Session 4: Responsible Conduct of Research & Organizing Your Study Team
May 3 - Session 5: Institutional Resources

Session 4: Responsible Conduct of Research & Organizing Your Study Team

		RCR: Case Scenarios—Michele Kennett, JD, Associate Vice Chancellor for Research, Research Compliance, MU
		Clinicaltrials.gov: Case Scenarios—Michelle Jenkerson, RPA, Rn, Associate Director, Clinical Research, Center for Clinical Studies, Washington University-St. Louis
		Organizing your Study Team—Stacee Baker, RN, Director of Research Operations and Planning, Department of Orthopaedic Surgery MU, James Cook, DVM, PhD, William & Kathryn Allen Distinguished Chair in Orthopaedic Surgery, Director, Thompson Laboratory for Regenerative Orthopaedics, Chief, Orthopaedic Research Division, and Director of Operations & Research, Mizzou BioJoint Center, MU
		Clinical Data & Engagement Methods—James McClay, MD, MS, FACEP, FAMIA, Professor, Health Management & Informatics, Chief Research Informatics Officer, School of Medicine, MU
		Myths & Realities of Research Funding—Rick Barohn, MD, Executive Vice Chancellor for Health Affairs, Executive Director, NextGen Precision Health and Hugh E. and Sarah D. Stephenson Dean, School of Medicine, MU